United States - English - NLM (National Library of Medicine)

apex energetics inc. - lactose, unspecified form (unii: j2b2a4n98g) (anhydrous lactose - unii:3sy5lh9pmk), thuja occidentalis leafy twig (unii: 1nt28v9397) (thuja occidentalis leafy twig - unii:1nt28v9397), potassium sulfate (unii: 1k573lc5tv) (potassium cation - unii:295o53k152), goldenseal (unii: zw3z11d0jv) (goldenseal - unii:zw3z11d0jv), potassium dichromate (unii: t4423s18fm) (dichromate ion - unii:9lky4bfn2v), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152), pulsatilla vulgaris (unii: i76kb35jev) (pulsatilla vulgaris - unii:i76kb35jev), phosphorus (unii: 27ylu75u4w) (phosphorus - unii:27ylu75u4w), skim milk (unii: 6a001y4m5a) (skim milk - unii:6a001y4m5a), calcium iodide (unii: 8eki9qee2h) (calcium cation - unii:2m83c4r6zb), echinacea angustifolia (unii: vb06av5us8) (echinacea angustifolia whole - unii:vb06av5us8), echinacea purpurea (unii: qi7g114y98) (echinacea purpurea whole - unii:qi7g114y98), euphorbia resinifera resin (unii: 1ti1o9028k) (euphorbia resinifera resin - unii:1ti1o9028k), calcium sulfide (unii: 1mbw07j51q) (calcium sulfide - unii:1mbw07j51q), histamine dihydrochloride (unii: 3poa0q644u) (histamine - unii:820484n8i3), mercuric sulfide (unii: zi0t668sf1) (mercuric cation - unii:ed30fj8y42), onion (unii: 492225q21h) (onion - unii:492225q21h), calcium sulfate anhydrous (unii: e934b3v59h) (calcium cation - unii:2m83c4r6zb), luffa operculata fruit (unii: c4mo6809hu) (luffa operculata fruit - unii:c4mo6809hu) - for temporary relief of minor: sinus congestion* coughing* fatigue* nasal discharge* frontal headache* muscle aches* *claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated.

United States - English - NLM (National Library of Medicine)

s+ - octinoxate (unii: 4y5p7mud51) (octinoxate - unii:4y5p7mud51), octisalate (unii: 4x49y0596w) (octisalate - unii:4x49y0596w), titanium dioxide (unii: 15fix9v2jp) (titanium dioxide - unii:15fix9v2jp) - - helps protect against sunburn.

Singapore - English - HSA (Health Sciences Authority)

astrazeneca singapore pte ltd - bicalutamide - tablet, film coated - 150 mg - bicalutamide 150 mg

Singapore - English - HSA (Health Sciences Authority)

dksh singapore pte. ltd. - atenolol - tablet, film coated - 50 mg - atenolol 50 mg

Israel - English - Ministry of Health

rafa laboratories ltd - fentanyl - patches - fentanyl 100 mcg/hour - fentanyl - management of chronic pain and intractable pain requiring opioid analgesia.fenta should only be used in patients who are already receiving opioid therapy who have demonstrated opioid tolerance.

Israel - English - Ministry of Health

rafa laboratories ltd - fentanyl - patches - fentanyl 25 mcg/hour - fentanyl - management of chronic pain and intractable pain requiring opioid analgesia.fenta should only be used in patients who are already receiving opioid therapy who have demonstrated opioid tolerance.

Israel - English - Ministry of Health

rafa laboratories ltd - fentanyl - patches - fentanyl 50 mcg/hour - fentanyl - management of chronic pain and intractable pain requiring opioid analgesia.fenta should only be used in patients who are already receiving opioid therapy who have demonstrated opioid tolerance.

Israel - English - Ministry of Health

rafa laboratories ltd - fentanyl - patches - fentanyl 75 mcg/hour - fentanyl - management of chronic pain and intractable pain requiring opioid analgesia.fenta should only be used in patients who are already receiving opioid therapy who have demonstrated opioid tolerance.

Israel - English - Ministry of Health

novartis israel ltd - epoetin alfa - solution for injection - epoetin alfa 1000 iu / 0.5 ml - erythropoietin - erythropoietin - binocrit® is indicated for the treatment of symptomatic anaemia associated with chronic renal failure (crf):- in adults and children aged 1 to 18 years on haemodialysis and adult patients on peritoneal dialysis .- in adults with renal insufficiency not yet undergoing dialysis for the treatment of severe anaemia of renal origin accompanied by clinical symptoms in patients. binocrit® is indicated in adult patients receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma, and at risk of transfusion as assessed by the patient's general status (e.g. cardiovascular status, pre existing anaemia at the start of chemotherapy) for the treatment of anaemia and reduction of transfusion requirements.binocrit® is indicated in adults in a predonation programme to increase the yield of autologous blood.treatment should only be given to patients with moderate anaemia (haemoglobin (hb) concentration range between 10 13 g/dl (6.2 8.1 mmol/l), no iron deficiency), if blood saving procedures are not available or insufficient when the scheduled major elective surgery requires a large volume of blood (4 or more units of blood for females or 5 or more units for males).binocrit® is indicated for non-iron deficient adults prior to major elective orthopaedic surgery, having a high perceived risk for transfusion complications to reduce exposure to allogeneic blood transfusions.use should be restricted to patients with moderate anaemia (e.g. hb concentration range between 10 13 g/dl or 6.2 8.1 mmol/l) who do not have an autologous predonation programme available and with an expected blood loss (900 to 1800 ml).

Israel - English - Ministry of Health

novartis israel ltd - epoetin alfa - solution for injection - epoetin alfa 2000 iu / 1 ml - erythropoietin - erythropoietin - binocrit® is indicated for the treatment of symptomatic anaemia associated with chronic renal failure (crf):- in adults and children aged 1 to 18 years on haemodialysis and adult patients on peritoneal dialysis .- in adults with renal insufficiency not yet undergoing dialysis for the treatment of severe anaemia of renal origin accompanied by clinical symptoms in patients. binocrit® is indicated in adult patients receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma, and at risk of transfusion as assessed by the patient's general status (e.g. cardiovascular status, pre existing anaemia at the start of chemotherapy) for the treatment of anaemia and reduction of transfusion requirements.binocrit® is indicated in adults in a predonation programme to increase the yield of autologous blood.treatment should only be given to patients with moderate anaemia (haemoglobin (hb) concentration range between 10 13 g/dl (6.2 8.1 mmol/l), no iron deficiency), if blood saving procedures are not available or insufficient when the scheduled major elective surgery requires a large volume of blood (4 or more units of blood for females or 5 or more units for males).binocrit® is indicated for non-iron deficient adults prior to major elective orthopaedic surgery, having a high perceived risk for transfusion complications to reduce exposure to allogeneic blood transfusions.use should be restricted to patients with moderate anaemia (e.g. hb concentration range between 10 13 g/dl or 6.2 8.1 mmol/l) who do not have an autologous predonation programme available and with an expected blood loss (900 to 1800 ml).